SCHEMBL31246045

SCHEMBL31246045

Cc1ccc(S(=O)(=O)n2cc(-c3ccncc3)c3cncnc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
PTPN11 Q06124 1/20 0.43
MKNK2 Q9HBH9 1/20 0.41
KDR P35968 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPK14 Q16539 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
POLB P06746 1/20 0.37
ALDH3A1 P30838 1/20 0.37
HTT P42858 1/20 0.37
NOD1 Q9Y239 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GBA1 P04062 2/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26969480 0.80 L3MBTL1 (0.37) HTR6L3MBTL1PTPN11MEN1KMT2A
SCHEMBL29605374 0.80 L3MBTL1 (0.37) HTR6L3MBTL1PTPN11MEN1KMT2A
SCHEMBL13834845 0.80 BRD4 (0.45) HTR6L3MBTL1PTPN11MEN1KMT2A
SCHEMBL5074943 0.80 CA1 (0.48) HTR6L3MBTL1PTPN11CA2POLB
SCHEMBL25422336 0.79 HTR6 (0.61) HTR6L3MBTL1MEN1KMT2ACA2
SCHEMBL30461646 0.79 HTR6 (0.61) HTR6L3MBTL1MEN1KMT2ACA2
SCHEMBL13835162 0.77 HSD11B1 (0.41) HTR6L3MBTL1PTPN11MEN1KMT2A
SCHEMBL29387065 0.77 PTPN11 (0.38) L3MBTL1PTPN11MEN1KMT2ACA2
SCHEMBL8944259 0.76 L3MBTL1 (0.67) HTR6L3MBTL1PTPN11CA2CA9
SCHEMBL19320346 0.76 PIM1 (0.40) HTR6L3MBTL1PTPN11POLBALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4687883-A2 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE Caraway Therapeutics, Inc. (US) 2026-02-11 EP disclosed
WO-2024211249-A2 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2024-10-10 WO disclosed